The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies
Sign Up to like & getrecommendations! Published in 2019 at "BMC Veterinary Research"
DOI: 10.1186/s12917-019-1811-2
Abstract: BackgroundA previous six-week (wk) study demonstrated the potential of the sodium-glucose linked transport inhibitor velagliflozin as a novel treatment for equine insulin dysregulation. The present study examined the safety and efficacy of velagliflozin over 16… read more here.
Keywords: insulin; treatment; safety; velagliflozin ... See more keywords